menu search

galecto to present at investor conferences in september

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology ...

August 31, 2023, 11:00 am

galecto (glto) down 71% as lung disease candidate fails

galecto's (GLTO) shares fall as the mid-stage study of GB0139 to treat idiopathic pulmonary fibrosis fa...

August 16, 2023, 9:28 am

galecto announces topline results from phase 2b galactic-1 trial of gb0139 for the treatment of idiopathic pulmonary fibrosis

Announces next steps for clinical development plan in severe liver diseases BOSTON, Aug. 15, 2023 (GLOBE NEWSWIRE) — ...

August 15, 2023, 11:30 am

galecto shares drop 65% as biotech halts development of lung-disease treatment

Shares of galecto Inc. GLTO dropped 65% in premarket trading Tuesday after the biotech company said it ...

August 15, 2023, 8:39 am

galecto to discontinue development of lung disease treatment

Drug developer galecto said on Tuesday it will discontinue development of its lung disease treatment af...

August 15, 2023, 7:55 am

Orbimed advisors llc reduces stake in galecto inc

On July 25, 2023, ORBIMED ADVISORS LLC (Trades, Portfolio), a renowned investment firm, reduced its stake in g...

July 27, 2023, 10:02 pm

galecto reports first quarter operating and financial results

BOSTON, April 28, 2023 (GLOBE NEWSWIRE) — galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnolog...

April 28, 2023, 12:00 pm

Orbimed advisors now owns 10.5% of galecto

Fintel reports that Orbimed Advisors has filed a 13D/A form with the SEC disclosing ownership of 2.70MM shares of ...

April 10, 2023, 10:21 pm

All you need to know about galecto, inc. (glto) rating upgrade to strong buy

galecto, Inc. (GLTO) might move higher on growing optimism about its earnings prospects, which is refle...

November 11, 2022, 1:33 pm


Search within

Pages Search Results: